Perfil
Matthew P.
Ottmer worked as Senior VP-Strategy & Emerging Businesses at Biogen, Inc. from 2014 to 2015, followed by a position as Chief Operating Officer at Momenta Pharmaceuticals, Inc. from 2015 to 2017.
He then became President at Bioverativ Therapeutics, Inc. before serving as Chief Operating Officer at Voyager Therapeutics, Inc. from 2017 to 2020.
Ottmer received his undergraduate degree from the University of Michigan and his MBA from Kellogg School of Management.
Antiguos cargos conocidos de Matthew P. Ottmer.
| Empresas | Cargo | Fin |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Director de Operaciones | 12/02/2020 |
| MOMENTA PHARMACEUTICALS, INC. | Director de Operaciones | 01/04/2017 |
| BIOGEN INC. | Corporate Officer/Principal | 01/07/2015 |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Presidente | - |
Formación de Matthew P. Ottmer.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
- Bolsa de valores
- Insiders
- Matthew P. Ottmer
















